Citation Impact
Citing Papers
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Advances in mass spectrometry-based clinical biomarker discovery
2016
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
2009
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Herceptin
2007
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening
2009
Frequency of Symptoms of Ovarian Cancer in Women Presenting to Primary Care Clinics
2004
Ovarian cancer
2014 Standout
Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125)
2006
The antral follicle count: practical recommendations for better standardization
2009
BRCA1 : mechanisms of inactivation and implications for management of patients
2002
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
2009
Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries
2005
Current Management Strategies for Ovarian Cancer
2007
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Polycystic Ovaries Are Common in Women with Hyperandrogenic Chronic Anovulation but Do Not Predict Metabolic or Reproductive Phenotype
2005
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer
2007
Recent developments in ovarian cancer screening
2000
Ovarian Volume throughout Life: A Validated Normative Model
2013
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial
2009
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
2010 Standout
Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation
2002
B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression
2007
Cisplatin: The first metal based anticancer drug
2019 Standout
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Wound dressings – a review
2015 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
A review of the carcinogenic potential of bisphenol A
2015
Polycystic ovary syndrome
2016 Standout
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Use of proteomic patterns in serum to identify ovarian cancer
2002 Standout
Artificial intelligence in healthcare
2018 Standout
Ovarian cancer screening in the general population: current status
2001
Neoplasia of the Female Reproductive Tract: Effects of Hormone Therapy
2004
Three-Dimensional Power Doppler Ultrasound Improves the Diagnostic Accuracy for Ovarian Cancer Prediction
2001
Cancer of the Ovary
2004 Standout
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
2013
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
2010 StandoutNobel
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
2002
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
2002
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
2004
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Current Management Strategies for Ovarian Cancer
2007
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Polycystic Ovarian Morphology in Normal Women Does Not Predict the Development of Polycystic Ovary Syndrome
2006
Ovarian cancer statistics, 2018
2018 Standout
International Statistical Classification of Diseases and Related Health Problems
2014 Standout
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age
2009
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Hereditary breast cancer
2001
Works of F. Ueland being referenced
The Malignant Potential of Small Cystic Ovarian Tumors in Women over 50 Years of Age
1998
The Efficacy of Transvaginal Sonographic Screening in Asymptomatic Women at Risk for Ovarian Cancer
2000
Ultrasound evaluation of pelvic masses: predictors of malignancy for the general gynecologist
1999
Ovarian Volume Related to Age
2000
Clinical performance of a multivariate index assay for detecting early-stage ovarian cancer
2013
Results from a phase II randomized, placebo-controlled, double-blind trial suggest improved PFS with the addition of pertuzumab to gemcitabine in patients with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer
2007